慢性阻塞性肺病中的脂ophagy:机制性见解和新兴的治疗点
Yide Wang1, Yidie Bao2, Xinliao Deng2
1Department of Rehabilitation, The Fourth Clinical Medical College of Xinjiang Medical University, Urumqi 830000, China; School of Rehabilitation Science, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
|February 24, 2026
概括
脂ophagy,一个细胞过程,通过影响脂质代谢和炎症,在慢性阻塞性肺病 (COPD) 中发挥关键作用. 调节脂质可能为COPD提供新的治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 代谢途径 代谢途径
- 肺部医学 肺部医学
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种进展性肺病,治疗选择有限.
- 脂质代谢和炎症越来越被认为是COPD病变的关键因素.
- 脂质,即通过自来降解脂质滴,是COPD中这些过程的潜在调节者.
研究的目的:
- 审查和整合目前关于脂质在COPD中的作用的证据.
- 探索脂质如何影响细胞代谢,并与COPD的关键疾病机制相互作用.
- 评估针对COPD治疗的向脂质的翻译潜力.
主要方法:
- 这是一个综合现有研究结果的叙述性综述.
- 该评论批判性地讨论了将脂质与COPD中的代谢途径和病原性过程联系在一起的证据.
- 它检查了脂质对炎症,氧化应激和器官功能的影响.
主要成果:
- 慢性肺炎的脂质失衡与脂质代谢的改变有关,包括脂质滴滴的积累.
- 不调节的脂质有助于COPD的炎症,氧化应激,蛋白质稳定性破坏和亡.
- 损伤的脂质也会影响肺外组织,如骨肌肉.
结论:
- 脂质是代谢,器官质量控制和COPD炎症的关键因素.
- 恢复平衡的脂质可以改善细胞生物能学和减少脂质毒性.
- 向脂质化为管理COPD进展的新型治疗干预措施提供了一个有希望的途径.
更多相关视频
相关概念视频
01:20COPD: Pathogenesis and Clinical Features
2.0K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.3K
01:24Chronic Obstructive Pulmonary Disease
2.7K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:26COPD: Management Using Bronchodilators and Corticosteroids
942
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
942